Carbon nanotube membranes for use in the transdermal treatment of nicotine addiction and opioid withdrawal symptoms

Caroline L. Strasinger, Nicole N. Scheff, Ji Wu, Bruce J. Hinds, Audra L. Stinchcomb

Research output: Contribution to journalArticlepeer-review

21 Scopus citations
3 Downloads (Pure)

Abstract

Transdermal systems are attractive methods of drug administration specifically when treating patients for drug addiction. Current systems however are deficient in therapies that allow variable flux values of drug, such as nicotine for smoking cessation or complex dosing regimens using clonidine when treating opioid withdrawal symptoms. Through the use of functionalized carbon nanotube (CNT) membranes, drug delivery to the skin can be controlled by applying a small electrical bias to create a programmable drug delivery system. Clearly, a transdermal patch system that can be tailored to an individual's needs will increase patient compliance as well as provide much more efficient therapy. The purpose of this paper is to discuss the applicability of using carbon nanotube membranes in transdermal systems for treatment of drug abuse.

Original languageEnglish
Pages (from-to)31-39
Number of pages9
JournalSubstance Abuse: Research and Treatment
Volume3
Issue number1
DOIs
StatePublished - 2009

Scopus Subject Areas

  • Psychiatry and Mental health

Keywords

  • Clonidine
  • Cnt
  • Nicotine
  • Transdermal delivery
  • Variable rate

Fingerprint

Dive into the research topics of 'Carbon nanotube membranes for use in the transdermal treatment of nicotine addiction and opioid withdrawal symptoms'. Together they form a unique fingerprint.

Cite this